0001493152-23-041138.txt : 20231114 0001493152-23-041138.hdr.sgml : 20231114 20231114161945 ACCESSION NUMBER: 0001493152-23-041138 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20231114 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20231114 DATE AS OF CHANGE: 20231114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Notable Labs, Ltd. CENTRAL INDEX KEY: 0001603207 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36581 FILM NUMBER: 231406657 BUSINESS ADDRESS: STREET 1: 320 HATCH DRIVE CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 415-851-2410 MAIL ADDRESS: STREET 1: 320 HATCH DRIVE CITY: FOSTER CITY STATE: CA ZIP: 94404 FORMER COMPANY: FORMER CONFORMED NAME: Vascular Biogenics Ltd. DATE OF NAME CHANGE: 20140320 8-K 1 form8-k.htm
false 0001603207 0001603207 2023-11-14 2023-11-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 14, 2023

 

NOTABLE LABS, LTD.

(Exact name of registrant as specified in charter)

 

Israel   001-36581   Not Applicable

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

 

320 Hatch Drive        
Foster City, California       94404
(Address of principal executive offices)       (Zip Code)

 

Registrant’s telephone number, including area code: (415) 851-2410

 

N/A

(Former name or former address, if changed since last report)

 

Securities registered or to be registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Ordinary Shares, par value NIS 0.35 each   NTBL   The Nasdaq Capital Market

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Item 2.02 Results of Operations and Financial Condition

 

On November 14, 2023, Notable Labs, Ltd. (the “Company”) issued a press release announcing the filing of its financial results for the third quarter ended September 30, 2023 and providing a business update and additional financial information. A copy of the press release is furnished herewith as Exhibit 99.1.

 

The information in Item 2.02 of this Current Report on Form 8-K, including the information in the press release attached as Exhibit 99.1 to this Current Report on Form 8-K, is furnished pursuant to Item 2.02 of Form 8-K and shall not be deemed “filed” for the purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section. Furthermore, the information in Item 2.02 of this Current Report on Form 8-K, including the information in the press release attached as Exhibit 99.1 to this Current Report on Form 8-K, shall not be deemed to be incorporated by reference in the filings of the Company under the Securities Act.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
     
99.1   Press Release issued November 14, 2023
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  NOTABLE LABS, LTD.
     
Date: November 14, 2023 By: /s/ Thomas A. Bock
  Name: Thomas A. Bock
  Title: Chief Executive Officer

 

 

 

 

 EX-99.1 2 ex99-1.htm

 

Exhibit 99.1

 

 

Notable Labs Announces Filing of Form 10-Q for Third Quarter 2023

 

-Summarizes third quarter 2023 financials of pre-Merger VBLT as of September 30th-

 

-Third quarter financial information of Notable Labs, Inc. and pro forma combined financial information of Notable Labs, Ltd. will be subsequently provided via Form 8-K later in November-

 

FOSTER CITY, Calif., November 14, 2023 – Notable Labs, Ltd. (“Notable”) (Nasdaq: NTBL), a clinical stage therapeutic platform company developing predictive precision medicines for cancer patients, today announced that it has filed its Quarterly Report on Form 10-Q containing financial results for the third quarter and nine months ended September 30, 2023. Due to the timing of the closing of Notable’s merger with VBL Therapeutics in October 2023, the Form 10-Q contains financial results of pre-merger VBL Therapeutics.

 

In October, Notable closed the previously announced merger with VBL Therapeutics. Concurrent with the merger, shares of Notable began public trading on the Nasdaq market under the symbol NTBL on October 17th, 2023. The combined company is focusing on the advancement of Notable’s proprietary PPMP platform and a therapeutic pipeline focused on cancer patients with high unmet medical needs while completing the development of Volasertib for the treatment of acute myeloid leukemia (AML) in platform-predicted responders as the lead program.

 

As of October 31, 2023, the post-Merger Company, Notable Labs, Ltd, had cash and cash equivalents of $14.3 million. Third quarter financial information of Notable Labs, Inc. and pro forma combined financial information of Notable Labs, Ltd. will be provided via Form 8-K later in November.

 

Safety and efficacy data from the Phase 2a trial (NCT04956042) for Fosciclopirox, being co-developed with Ciclomed, in adult patients with relapsed/refractory AML are anticipated before year-end 2023.

 

About Notable Labs, Inc.

 

Notable Labs, Ltd. is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment and aims to predict whether or not a patient is likely to respond to that specific therapeutic. Notable’s PPMP is designed to identify and select clinically responsive patients prior to their treatment and thus fast-track clinical development in this patient population. By continually advancing and expanding the reach of the PPMP across diseases and predicted medical outcomes, Notable aims to be the leader in precision medicine and revolutionize the way in which patients seek and receive treatments that work best for them – patient by patient and cancer by cancer. Notable believes it has created a targeted and de-risked in-licensing strategy to deliver a product’s medical impact and commercial value faster, higher, and with a greater likelihood of success than traditional drug development. By transforming historical standards of care, Notable aims to create dramatic positive impact for patients and the healthcare community. Notable is headquartered in Foster City, California. Learn more at www.notablelabs.com and follow us @notablelabs.

 

 

 

 

 

Forward Looking Statements

 

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, express or implied statements regarding Notable’s future operations and goals; the potential benefits of any therapeutic candidates or platform technologies of Notable; the timing of any clinical milestones of Notable’s therapeutic candidates; the cash runway of the combined company; and other statements that are not historical fact. All statements other than statements of historical fact contained in this communication are forward-looking statements. These forward-looking statements are made as of the date they were first issued, and were based on the then-current expectations, estimates, forecasts, and projections, as well as the beliefs and assumptions of management. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond Notable’s control. Notable’s actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to (i) uncertainties associated with Notable’s platform technologies, as well as risks associated with the clinical development and regulatory approval of product candidates, including potential delays in the commencement, enrollment and completion of clinical trials; (ii) risks related to the inability of Notable to obtain sufficient additional capital to continue to advance these product candidates and any preclinical programs; (iii) uncertainties in obtaining successful clinical results for product candidates and unexpected costs that may result therefrom; (iv) risks related to the failure to realize any value from product candidates and preclinical programs being developed and anticipated to be developed in light of inherent risks and difficulties involved in successfully bringing product candidates to market; (v) risks associated with Notable’s future financial and operating results, including its ability to become profitable; (vi) Notable’s ability to retain key personnel; (vii) Notable’s ability to manage the requirements of being a public company; (viii) uncertainties relating to the Israel-Hamas war; (ix) Notable’s ability to obtain orphan drug designation, and the associated benefits, for any of its drug candidates; (x) Notable’s inability to obtain regulatory approval for any of its drug candidates; and (xi) changes in, or additions, to international, federal, state or local legislative requirements, such as changes in or additions to tax laws or rates, pharmaceutical regulations, and other regulations. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties. These and other risks and uncertainties are more fully described in periodic filings with the U.S. Securities and Exchange Commission (“SEC”), including the factors described in the section titled “Risk Factors” in the Registration Statement of Vascular Biogenics Ltd. on Form S-4, as filed with the SEC on September 1, 2023, the Quarterly Report on Form 10-Q of Notable Labs, Ltd. as filed with the SEC on November 14, 2023, and in other subsequent filings with the SEC. You should not place undue reliance on these forward-looking statements, which are made only as of the date hereof or as of the dates indicated in the forward-looking statements. Notable expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.

 

CONTACTS:

 

Investor Relations: Daniel Ferry, LifeSci Advisors

+1 (617) 430-7576, daniel@lifesciadvisors.com

 

 

 

 GRAPHIC 3 ex99-1_001.jpg begin 644 ex99-1_001.jpg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end EX-101.SCH 4 ntbl-20231114.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 5 ntbl-20231114_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 ntbl-20231114_pre.xml XBRL PRESENTATION FILE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover
Nov. 14, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Nov. 14, 2023
Entity File Number 001-36581
Entity Registrant Name NOTABLE LABS, LTD.
Entity Central Index Key 0001603207
Entity Incorporation, State or Country Code L3
Entity Address, Address Line One 320 Hatch Drive
Entity Address, City or Town Foster City
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94404
City Area Code (415)
Local Phone Number 851-2410
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Ordinary Shares, par value NIS 0.35 each
Trading Symbol NTBL
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 8 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001603207 2023-11-14 2023-11-14 iso4217:USD shares iso4217:USD shares false 0001603207 8-K 2023-11-14 NOTABLE LABS, LTD. L3 001-36581 320 Hatch Drive Foster City CA 94404 (415) 851-2410 Ordinary Shares, par value NIS 0.35 each NTBL NASDAQ false false false false false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

JQ"(6,P$ "(" / " 3D0 !X;"]W M;W)K8F]O:RYX;6Q02P$"% ,4 " !U@FY7)!Z;HJT #X 0 &@ M @ &9$0 >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 M " !U@FY799!YDAD! #/ P $P @ %^$@ 6T-O;G1E C;G1?5'EP97-=+GAM;%!+!08 "0 ) #X" #($P ! end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 21 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://notablelabs.com/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm ntbl-20231114.xsd ntbl-20231114_lab.xml ntbl-20231114_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form8-k.htm": { "nsprefix": "NTBL", "nsuri": "http://notablelabs.com/20231114", "dts": { "inline": { "local": [ "form8-k.htm" ] }, "schema": { "local": [ "ntbl-20231114.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "ntbl-20231114_lab.xml" ] }, "presentationLink": { "local": [ "ntbl-20231114_pre.xml" ] } }, "keyStandard": 21, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 21 }, "report": { "R1": { "role": "http://notablelabs.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2023-11-14", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-11-14", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true } } }, "tag": { "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://notablelabs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 16 0001493152-23-041138-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-041138-xbrl.zip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end